Precision Medicine

Precision medicine uses genomic information to improve diagnosis, risk assessment, treatment selection, and patient care. By connecting molecular variation to clinical decision-making, this field transforms genomic knowledge into individualized medicine.

Research Overview

Precision medicine moves beyond one-size-fits-all healthcare by integrating genomic information into clinical care. It helps clinicians understand which patients are at risk, which therapies are most likely to work, and which genomic findings are relevant for diagnosis, prognosis, and long-term management.

At PanorOmics, precision medicine is the clinical application of genomics: the point where sequencing, variant discovery, and interpretation become actionable for real patients. It bridges molecular biology, computational analysis, diagnostics, therapeutics, and longitudinal healthcare.

Core Research Areas

Cancer Genomics

Using tumor genomic profiling to guide diagnosis, prognosis, targeted therapy selection, and precision oncology decision-making.

Rare & Inherited Diseases

Identifying pathogenic variants to improve diagnosis, family counseling, disease classification, and individualized patient management.

Pharmacogenomics

Understanding how genetic variation influences drug metabolism, efficacy, toxicity, and precision prescribing.

Clinical Decision Support

Integrating genomic findings into routine healthcare through interpretation frameworks, evidence-based guidelines, and AI-assisted clinical workflows.

Clinical Workflow

Patient

A patient presents with clinical symptoms, cancer, inherited disease risk, or a need for precision treatment guidance.

Clinical Assessment

Clinicians evaluate history, symptoms, pathology, family background, and diagnostic context.

DNA Sequencing

Genomic testing is performed through clinical sequencing, targeted panels, exomes, or whole genomes.

Variant Discovery

Relevant inherited or somatic variants are detected and prioritized from sequencing data.

Clinical Interpretation

Variants are linked to genes, disease mechanisms, evidence levels, therapeutic implications, and reporting standards.

Treatment Selection

Genomic results inform diagnosis, targeted therapy, surveillance, risk assessment, and patient-specific care plans.

Patient Follow-up

Longitudinal monitoring tracks response, progression, resistance, and future precision care decisions.

Clinical Technologies

Clinical NGS

Clinical next-generation sequencing platforms support inherited disease testing, oncology panels, and precision diagnostics.

Liquid Biopsy

Blood-based genomic testing enables noninvasive detection of tumor-derived DNA, monitoring, and resistance tracking.

Companion Diagnostics

Molecular assays connect specific genomic biomarkers to therapeutic eligibility and treatment selection.

Polygenic Risk Scores

Aggregated genetic risk models support disease risk stratification and preventive precision medicine.

Digital Pathology

Computational pathology and molecular pathology integration enhance precision diagnosis and tumor classification.

AI Clinical Decision Support

AI-assisted systems help interpret genomic findings, prioritize evidence, and support clinical recommendations.

Clinical Applications

Oncology

Precision genomics guides molecular classification, targeted therapies, resistance analysis, and immunotherapy biomarkers.

Rare Disease

Genome-informed diagnosis improves disease discovery, family counseling, and clinical management.

Cardiovascular Medicine

Genomic risk, inherited cardiomyopathies, arrhythmia syndromes, and precision prevention strategies are increasingly integrated into care.

Neurological Disorders

Genetic testing supports diagnosis and subtype classification of neurodevelopmental and neurodegenerative disease.

Prenatal & Newborn Care

Genomic testing informs screening, early diagnosis, and personalized clinical intervention in developmental disorders.

Pharmacology

Drug-gene relationships help optimize dosing, reduce toxicity, and improve treatment response.

Landmark Discoveries

1990–2003

Human Genome Project

Established the genomic foundation for modern molecular medicine, clinical genomics, and precision healthcare.

1994–1995

BRCA1 / BRCA2 Discovery

The discovery of BRCA1 and BRCA2 helped establish inherited cancer genetics as an early model for genomic risk assessment.

1998

HER2-Targeted Therapy

FDA approval of trastuzumab for HER2-positive breast cancer showed how biomarker-guided therapy could transform oncology.

2003–2015

EGFR-Targeted Lung Cancer Therapy

EGFR-targeted therapy and later mutation-matched approvals helped make tumor genomic profiling central to precision oncology.

2009–Present

Pharmacogenomics Implementation

Clinical pharmacogenomics guidelines increasingly support personalized prescribing and drug-response prediction.

2010s–Present

Clinical Genomic Testing

Tumor profiling, inherited disease testing, and sequencing-based diagnostics increasingly integrate genomics into routine clinical decision-making.

Present

AI-Assisted Precision Medicine

AI increasingly supports genomic interpretation, biomarker analysis, clinical decision support, and precision medicine research.

Featured Publications

A Strategy for Using Multigene Testing in Precision Oncology

Precision oncology and biomarker-guided treatment studies
Nature Reviews Clinical Oncology / NEJM

Identification of BRCA1 and BRCA2 in Hereditary Cancer Risk

Foundational inherited cancer genomics studies
Science / Nature Genetics

HER2 as a Therapeutic Target in Breast Cancer

Targeted therapy landmark studies
Science / NEJM

EGFR Mutations and Targeted Therapy in Lung Cancer

Clinical genomics and precision oncology studies
NEJM / Science Translational Medicine

Pharmacogenomics in Clinical Practice

Precision prescribing and genomic medicine implementation studies
Clinical Pharmacology & Therapeutics

Genome Sequencing for Diagnosis in Rare Disease

Clinical genomics diagnostic studies
NEJM / Genetics in Medicine

Explore Publications Library →